This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0313U only for PancreaSeq® Genomic Classifier from University of Pittsburgh Medical Center Molecular and Genomic Pathology Laboratory. Using fluid from a pancreatic cyst identified by imaging, the test uses next–generation sequencing (NGS) analysis of 74 genes and gene [removed]RNA) analysis of a gene known as carcinoembryonic antigen (CEA) or carcinoembryonic antigen–related cell adhesion molecule 5 (CEACAM5), which is a biomarker for gastrointestinal cancers. Using an algorithmic analysis of the results, the test provides a probability score of negative (low probability) or positive (high probability) that the cyst harbors genetic changes that could lead to cancer.
For clinical responsibility, terminology, tips and additional info
start codify free trial.